Regulation of IGFBP3 gene expression in short children born small for gestational age

Growth Hormone and IGF Research

Volumn 21, Issue 6, 2011, Pages 349-355

  Faienza, M F ^a   Marzano, F ^a   Ventura, A M ^a   Wasniewska, M ^b   Valenzise, M ^b   Valletti, A ^a   Caratozzolo, M F ^a,c   Cornacchia, S ^a,c   Sbisa E ^c   Cavallo, L ^a   Tullo, A ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR   (Italy)

Author keywords

Gene expression; Growth disorders; IGFBP3; Polymorphisms; Small for gestational age

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; INSULIN; THREONINE;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; OUTCOME ASSESSMENT; PREPUBERTY; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; SHORT STATURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; TANDEM REPEAT; TRANSCRIPTION REGULATION;

BIRTH WEIGHT; BODY HEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GESTATIONAL AGE; HCT116 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; ITALY; LUCIFERASES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 80055087954     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.09.003     Document Type: Article

References (28)

1. Klammt J., Pfäffle R., Werner H., Kiess W. IGF signaling defects as causes of growth failure and IUGR. Trends Endocrinol. Metab. 2008, 19(6):197-205.
2. Labarta J.I., Ruiz J.A., Molina I., De Arriba A., Mayayo E., Longás A.F. Growth and growth hormone treatment in short stature children born small for gestational age. Pediatr. Endocrinol. Rev. Feb 2009, 6(Suppl. 3):350-357.
3. Saenger P., Czernichow P., Hughes I., Reiter E.O. Small for gestational age: short stature and beyond. Endocr. Rev. 2007, 28(2):219-251.
4. Stewart C.E., Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 1996, 76(4):1005-1026.
5. Collett-Solberg P.F., Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000, 12(2):121-136.
6. Baxter R.C., Butt A.J., Schedlich L.J., Martin J.L. Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. Growth Horm IGF Res. 2000, 10(Suppl. A):S10-S11.
7. Firth S.M., McDougall F., McLachlan A.J., Baxter R.C. Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability. Endocrinology 2002, 143(5):1669-1676.
8. Phillips L.S., Pao C.I., Villafuerte B.C. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog. Nucleic Acid Res. Mol. Biol. 1998, 60:195-265.
9. Arends N., Johnston L., Hokken-Koelega A., et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J. Clin. Endocrinol. Metab. 2002, 87(6):2720.
10. -G1245A IGF1 polymorphism is related with small head size and less brain sparing in small for gestational age born children. Eur. J. Endocrinol. 2009, 160(4):549-555.
11. Van der Kaay D., Deal C., de Kort S., et al. Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age. J. Clin. Endocrinol. Metab. 2009, 94(4):1386-1392.
12. Deal C., Ma J., Wilkin F., et al. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J. Clin. Endocrinol. Metab. 2001, 86(3):1274-1280.
13. Paquette J., Bessette B., Ledru E., Deal C. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin. Endocrinology 2007, 148(12):6007-6018.
14. Bertino E., Spada E., Occhi L., Coscia A., Giuliani F., Gagliardi L., Gilli G., Bona G., Fabris C., De Curtis M., Milani S. Neonatal anthropometric chorts: the Italian neonatal study compared with other European studies. J. Pediatr. Gastroenterol. Nutr. 2010, 51(3):353-361.
15. Cacciari E., Milani S., Balsamo A., Spada E., Bona G., Cavallo L., Cerutti F., Gargantini L., Greggio N., Tonini G., Cicognani A. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J. Endocrinol. Invest. 2006, 29(7):581-593.
16. Xiao W., Oefner P.J. Denaturing high-performance liquid chromatography: a review. Hum. Mutat. 2001, 17(6):439-474.
17. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
18. Cubbage M.L., Suwanichkul A., Powell D.R. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J. Biol. Chem. 1990, 265(21):12642-12649.
19. Weedon M.N., Lettre G., Freathy R.M., Lindgren C.M., Voight B.F., Perry J.R., Elliott K.S., Hackett R., Guiducci C., Shields B., Zeggini E., Lango H., Lyssenko V., Timpson N.J., Burtt N.P., Rayner N.W., Saxena R., Ardlie K., Tobias J.H., Ness A.R., Ring S.M., Palmer C.N., Morris A.D., Peltonen L., Salomaa V., Diabetes Genetics Initiative, Wellcome Trust Case Control Consortium, Davey Smith G., Groop L.C., Hattersley A.T., McCarthy M.I., Hirschhorn J.N., Frayling T.M. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat. Genet. 2007, 39:1245-1250.
20. Efstratiadis A. Genetics of mouse growth. Int. J. Dev. Biol. 1998, 42:955-976.
21. Stewart C.E., Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 1996, 76:1005-1126.
22. Khandwala H.M., McCutcheon I.E., Flyvbjerg A., Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 2000, 21:215-244.
23. Phillips L.S., Pao C.I., Villafuerte B.C. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog. Nucleic Acid Res Mol. Biol. 1998, 60:195-265.
24. Deal C., Ma J., Wilkin F., Paquette J., Rozen F., Ge B., Hudson T., Stampfer M., Pollak M. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J. Clin. Endocrinol. Metab. 2001, 86:1274-1280.
25. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995, 377:646-649.
26. Huynh H., Yang X., Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J. Biol. Chem. 1996, 271:1016-1021.
27. Torrisi R., Parodi S., Fontana V., Pensa F., Casella C., Barreca A., De Palo G., Costa A., Decensi A. Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients. Int. J. Cancer 1998, 76:787-790.
28. Löfqvist C., Andersson E., Gelander L., Rosberg S., Hulthen L., Blum W.F., Wikland K.A. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J. Clin. Endocrinol. Metab. 2005, 90:1420-1427.